IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 1 - 20 of 1354 stories.
February 5, 2016
The mood among fine and specialty chemical manufacturers is still mostly upbeat, despite sluggish growth or recession in some emerging markets and increasing pressure on prices, according to attendees at Informex 2016, held this week in New Orleans....
February 2, 2016
Feature Pharma ingredients: New therapies, faster approvals drive growth Business is picking up for the active pharmaceutical ingredients (APIs) industry, and the outlook for the...
January 26, 2016
Johnson Matthey expands UK R&D facilities Johnson Matthey says it has expanded the R&D facilities at its Cambridge, UK, location. Additional capacity has been added in process...
January 21, 2016
Albany Molecular Research Inc. (AMRI; Albany, NY) says that Dawn Von Rohr will join AMRI as senior v.p./active pharmaceutical ingredient (API) business, effective 25 January. Von Rohr...
January 20, 2016
Altivia (Houston) has added capacity for the production of chloroacetyl chloride at its La Porte, TX, site by continuous phosgenation. Chloroacetyl chloride, a feedstock for the production of pharmaceuticals and agrochemicals, is now available in bulk from the La Porte facility, the company says....
January 20, 2016
Aesica Pharmaceuticals (Newcastle-upon-Tyne, UK) says that it has relocated development and clinical manufacturing services from Nottingham to Queenborough, UK. Aesica will now provide...
January 20, 2016
Johnson Matthey says it has expanded the R&D facilities at its Cambridge, UK, location. Capacity has been added in process R&D and in non-GMP production on a kilogram scale of...
January 19, 2016
Ampac Fine Chemicals today announced that Aslam Malik has been named president and CEO, effective 1 January. Malik replaces Joseph Carleone, who will remain as chairmand of Ampac's...
January 19, 2016
FDA issues warning letter to Hisun’s API plant in China The US FDA issued a warning letter on 31 December 2015 to the active pharmaceutical ingredient (API) manufacturing...
January 14, 2016
Lonza said on Wednesday that it is expanding mammalian production capacity at its Slough, UK facility. Based on increased demand for biopharmaceutical development and clinical...
January 13, 2016
The US FDA issued a warning letter on 31 December 2015 to the active pharmaceutical ingredient (API) manufacturing facility of Zhejiang Hisun Pharmaceutical—located at Taizhou...
January 12, 2016
Bayer has opened a large manufacturing site of traditional Chinese medicine (TCM) and Western medicine in the Majinpu bioengineering and pharmaceutical industrial park at Yunnan...
January 12, 2016
SAFC’s Gilles Cottier joins Patheon as head of pharmaceutical development services Patheon (Durham, NC), a provider of outsourced pharmaceutical development and manufacturing...
January 11, 2016
Patheon (Durham, NC), a provider of outsourced pharmaceutical development and manufacturing services, says that it has appointed Gilles Cottier as president of the company’s...
January 5, 2016
Pharmaceutical company Cadila Healthcare (Ahmedabad, India) informed the Bombay Stock Exchange (Mumbai) on 31 December 2015 that it has received a warning letter from the US FDA...
January 5, 2016
FDA issues warning letter to Cadila's API plant in India Pharmaceutical company Cadila Healthcare (Ahmedabad, India) informed the Bombay Stock Exchange (Mumbai) on 31 December 2015...
December 29, 2015
PCI Synthesis (Newburyport, MA), a manufacturer of new chemical entities, generic active pharmaceutical ingredients (APIs), and other specialty chemical products, has outlined the...
December 29, 2015
PCI Synthesis: US manufacturers to become more competitive as Chinese wages increase PCI Synthesis (Newburyport, MA), a manufacturer of new chemical entities (NCEs), generic active...
December 22, 2015
AMRI acquires Whitehouse Laboratories Albany Molecular Research Inc. (AMRI; Albany, NY) says that it has acquired Whitehouse Laboratories (Lebanon, NJ), a provider of testing services...
December 15, 2015
FDA warns of contamination of baclofen API from Taizhou Xinyou Pharmaceutical The US FDA, on 9 December, alerted drug manufacturers in the United States that certain lots of baclofen...
Pages:  [1] 2 3 4 5 6 7 8 9 10 Next »

contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa